HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Baucus Starts Early With Heath Care Proposal, Makes Prevention A Priority

This article was originally published in The Tan Sheet

Executive Summary

The Nov. 4 elections that added to the Democrats' House and Senate majorities also shook up congressional committees that handle health care-related legislation

You may also be interested in...



Baucus Maintains Public/Private Comparative Effectiveness Vision

Senate Finance Committee Chairman Max Baucus continues planning to include comparative effectiveness in the health care reform debate, even with research funding included in the American Recovery and Reinvestment Act

Daschle’s Exit Cedes Control Of Health Care Reform To Baucus, Waxman

The Obama administration's formula for making comprehensive health care reform work in 2009 was straightforward: have an experienced team in place in all of the relevant health and budget areas immediately; prepare a manageable piece of legislation for early in the first year; and rely on the political clout of the perfect political general to keep Congress focused and in line

HHS Secretary Daschle, OMB Director Orszag Set Tone For Health Care Reform

President-elect Barack Obama's selection of Tom Daschle for Health and Human Services secretary brings in a seasoned legislative strategist as the administration prepares to embark on health care reform

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS137507

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel